Breaking News - The Fly

Open Search

RPRX

Royalty Pharma

$

()

Royalty Pharma appoints Schneider as Chief Technology Officer

RPRX , VRSK

9/21/2023 - 08:26am

Ascendis Pharma price target raised to $113 from $107 at BofA

ASND , RPRX

9/7/2023 - 06:26am

Ascendis Pharma and Royalty Pharma enter into $150M royalty funding pact

ASND , RPRX

9/5/2023 - 16:05pm

Royalty Pharma, Ferring Pharma sign $500M royalty agreement for Adstiladrin

RPRX

8/24/2023 - 06:34am

Royalty Pharma acquires royalty on U.S. sales of Adstiladrin for up to $500M

RPRX

8/24/2023 - 05:11am

Royalty Pharma raises 2023 adjusted cash reciepts guidance

RPRX

8/8/2023 - 07:19am

Royalty Pharma reports Q2 revenue $538M, consensus $536.59M

RPRX

8/8/2023 - 07:17am

Biotech Alert: Searches spiking for these stocks today

NAVB , RPRX , OCGN

…

5/26/2023 - 11:21am

Royalty Pharma CEO Legorreta buys 150,000 class A ordinary shares

RPRX

5/24/2023 - 18:48pm

Royalty Pharma director sells $57.4M in common stock

RPRX

5/23/2023 - 07:35am

Royalty Pharma reports Q1 revenue $684M, consensus $852.9M

RPRX

5/9/2023 - 07:09am

Royalty Pharma price target raised to $50 from $48 at Morgan Stanley

RPRX

4/10/2023 - 07:36am

Royalty Pharma price target raised to $60 from $57 at Tigress Financial

RPRX

4/6/2023 - 16:08pm

Royalty Pharma announces $1B share repurchase program

RPRX

3/27/2023 - 07:36am

Biotech Alert: Searches spiking for these stocks today

CDTX , APTX , MCRB

…

3/24/2023 - 10:50am